New combo therapy aims to boost lung cancer survival
NCT ID NCT07632365
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new treatment plan for people with advanced non-small cell lung cancer that cannot be removed by surgery. Participants first receive chemotherapy plus immunotherapy, then radiation with more chemo, followed by additional immunotherapy. The goal is to see if this intensive approach can improve how long patients live without their cancer growing, while keeping side effects manageable. About 30 people will take part in this early-phase trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Chemotherapy combined with a PD-1 inhibitor (immunotherapy)
What this could lead to
If successful, this approach could improve long-term survival for people with advanced lung cancer that cannot be surgically removed.
What could go wrong
This is an early-phase trial with only 30 participants, so results may not apply to everyone. Combining treatments also raises the risk of serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Chest Hospital
Shanghai, Xuhui, 200052, China